Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,089
Closed -$333K 549
2024
Q3
$333K Sell
4,089
-195
-5% -$15.6K 0.01% 487
2024
Q2
$318K Sell
4,284
-1,072
-20% -$80.4K 0.01% 474
2024
Q1
$418K Sell
5,356
-665
-11% -$49.5K 0.01% 456
2023
Q4
$430K Sell
6,021
-1,013
-14% -$70.5K 0.02% 336
2023
Q3
$488K Sell
7,034
-808
-10% -$61.1K 0.02% 316
2023
Q2
$635K Sell
7,842
-708
-8% -$57.9K 0.03% 287
2023
Q1
$690K Sell
8,550
-680
-7% -$54.7K 0.04% 281
2022
Q4
$690K Buy
9,230
+1,725
+23% +$123K 0.04% 281
2022
Q3
$484K Sell
7,505
-105
-1% -$7.27K 0.03% 305
2022
Q2
$527K Buy
+7,610
New +$565K 0.03% 299

Other funds holding HOLX

Dana Investment Advisors's HOLX Position: Q4 2024 in Review

Dana Investment Advisors sold out of Hologic (HOLX) in Q4 2024, closing a stake of 4,089 shares — an estimated $333K sold.

Dana Investment Advisors first reported a position in HOLX in Q2 2022 and held it in 10 quarters. The position peaked at $690K in Q4 2022. 719 funds tracked by Wall St. Rank hold HOLX as of Q4 2024.

  • Dana Investment Advisors reported no remaining Hologic position as of Q4 2024 after selling out during the quarter.
  • Dana Investment Advisors sold 4,089 Hologic shares in Q4 2024, an estimated $333K.
  • Dana Investment Advisors first reported a position in Hologic in Q2 2022 and held it in 10 quarters.
  • Dana Investment Advisors's Hologic position peaked at $690K in Q4 2022.
  • 719 funds tracked by Wall St. Rank held Hologic as of Q4 2024.

Based on Dana Investment Advisors's 13F filing for Q4 2024, filed 6 Feb 2025.